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Abstract
A 24-year-old black male presented with a 1-week obstructive jaundice and intermittent abdominal pain, with no significant
weight loss and an unsuspicious abdominal exam. Blood chemistry showed a cholestatic pattern but a complete immuno-
logical and tumoral panel (anti-smooth muscle antibody, anti-mitochondrial antibody, anti-nuclear antibody, anti-neutrophil
cytoplasmic antibody, anti-Smith, anti-double-stranded-DNA antibody (anti-dsDNA), complement C3/C4, carcinoembryonic
antigen, CA 19-9 and IgG4) were all within normal limits. Abdominal ultrasound revealed dilatation of the intra and extra-
hepatic bile ducts. CT scan showed an abnormal dilatation of the distal bile duct but no focal enlargement of the head of the
pancreas. Endoscopic ultrasound suggested an inflammatory process but the magnetic resonance cholangio-pancreatography
favored a neoplastic obstruction of the distal common bile duct. Fine-needle aspiration cytology was insufficient for definitive
diagnosis and the patient underwent major surgery. Follow-up with mild exocrine pancreatic insufficiency treated with
enzyme replacement.
INTRODUCTION
The diagnosis and therapeutic management of autoimmune
pancreatitis (AIP) have always been challenging as AIP is a rare
pancreatic disorder with a clinical presentation that can some-
times mimic other forms of pancreatitis or even pancreatic
cancer [1].
CASE REPORT
A 24-year-old black male presented to the Emergency Department
with a 1-week obstructive jaundice and several episodes of inter-
mittent abdominal pain with irradiation to the left upper quadrant
and back. The patient denied known gallstones, night sweats,
fevers, fatigue, or weight loss and had an unremarkable past med-
ical history.
The abdominal exam revealed a soft, non-distended, non-
tender abdomen, without any palpable masses, organomegalies
or lymphadenopaties. Blood chemistry showed a cholestatic
pattern: bilirubin 6.61mg/dl, alkaline phosphatase 434 U/l,
gamma-glutamyl transpeptidase 374 U/l, alanine transaminase
542 U/l and aspartate transaminase 228 U/l. Lipase, amylase
and complete blood count showed regular values. Abdominal
ultrasound revealed dilatation of the intra and extrahepatic
bile ducts and the pancreas was enlarged and hypoechoic,
compatible with inflammation. CT scan was performed to dis-
card a neoplastic obstruction and confirmed an intrahepatic bil-
iary ductal dilatation (Fig. 1) and a dilatation of the distal bile
duct with no luminal lesions (Fig. 2).
Endoscopic retrograde cholangio-pancreatography (ERCP)
showed a lobular pancreas with an enhancing heterogeneous
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pseudonodular mass located in the pancreatic head. The main
pancreatic duct (MPD) appeared a well-defined non-beaded nar-
rowing duct. The common bile duct (CBD) showed no narrow-
ing or strictures until the intrapancreatic portion which
presented an irregular stenosis of 2 cm length and dilatation
upstream the area of stricture.
Laboratory tests including IgG4, anti-smooth muscle anti-
body (ASMA), anti-mitochondrial antibody (AMA), anti-nuclear
antibody (ANA), anti-neutrophil cytoplasmic antibody (ANCA),
anti-Sjogren’s-syndrome-related antigen A/B, anti-Smith (anti-
Sm), anti-dsDNA, complement C3/C4, CEA and CA 19-9 were all
negative. Endoscopic ultrasound (EUS) revealed a heteroge-
neous parenchyma of the pancreatic head and an EUS-FNA
was performed. The MRCP, on the other hand, suggested the
existence of a distal cholangiocarcinoma, because of the sud-
den typical stenosis in the distal CBD with a general dilatation
of the upper bile ducts (Fig. 3). Unfortunately, the biopsy was
not enough to establish a definitive diagnosis.
The patient was submitted to a pancreaticoduodenectomy.
Pathologic intraoperative examination was inconclusive for
malignant cells. The pathologic examination suggested a
chronic pancreatitis compatible with IgG4-related disease.
DISCUSSION
AIP is a type of rare chronic pancreatitis with a very low preva-
lence (0,9/ 100,000 individuals) and is twice more frequent in
men [1]. The clinical presentation is normally a painless
obstructive jaundice, like a pancreatic cancer, and acute pan-
creatitis is a rare initial presentation.
There are two histologic subgroups of AIP: type 1 or
Lymphoplasmacytic Sclerotic Pancreatitis (LPSP) includes dense
lymphoplasmacytic infiltrates, organized in a steriform pattern,
obliterative phlebitis and mild-to-moderate eosinophil infil-
trate. The etiology is not clear, but steroid therapy leads to a
permanent relief, so it is crucial to differentiate between AIP
and PC. AIP-type 1 is the pancreatic manifestation in the IgG4-
related disease spectrum (IgG4RD).
AIP-type 2 is not associated with IgG4RD and shows a classic
histological pattern of idiopathic duct-centric pancreatitis
(IDCP) with granulocytic epithelial lesions (GEL) [2]. There are
no diagnostic tests to diagnose the AIP-type and both are char-
acterized by focal or diffuse pancreatic enlargement accompan-
ied with a narrowing of the main pancreatic duct and IgG4
serum levels cannot establish a definitive diagnosis. The
International Consensus Diagnostic Criteria (ICDC) were devel-
oped in 2010, assembling the previous criteria [3–7].
Specific features in CT imaging for AIP suspicion are focal or
diffuse pancreatic enlargement with loss of the lobular shape
(sausage-shaped pancreas), a low-density rim surrounding the
pancreas and delayed homogenous enhancement during venous
phase [8], which were not present. The patient presented an
intrahepatic and distal bile duct dilatation but no pancreatic
masses or abnormal enlargements and no delayed homoge-
neous enhancement. If non-classic CT abdominal features, ERCP
can be very helpful in identifying the presence of a narrow stric-
ture (>one-third of the MPD) or multiple non-contiguous stric-
tures and absence of upstream dilatation from the stricture [9].
ERCP showed a pseudonodular mass in the head of the pancreas
but the pancreatic duct presented no strictures or irregular sten-
osis. Only the intrapancreatic portion of the common bile duct
presented an irregular 2 cm length stenosis and an upstream
dilatation, pointing to cholangiocarcinoma.
Corticosteroid treatments should not be initiated until the
possibility of malignancy is excluded, because some subtypes
Figure 3: ERCP. Heterogeneous pancreatic parenchyma and pseudonodular
appearance of the pancreatic head. Wirsung duct with no stenosis or obstruc-
tions. Common bile duct with normal caliber until the intrapancreatic portion
where a highly suspicious of malignancy 2 cm irregular stenosis is seen.
Figure 2: Pancreatic CT scan. Dilatation of the distal bile duct, with no evidence
of luminal lesions nor a pancreatic mass constricting the bile duct (endolum-
inal prosthesis).
Figure 1: Pancreatic CT scan. General dilatation of the intrahepatic biliary tree
and terminal common bile duct.
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of PC and pancreatic lymphoma can respond to this therapy.
CT scan features such as diffusely enlarged sausage-shaped
pancreas without a clear ductal pancreatic dilatation render
AIP more likely than PC, but if typical neoplastic features are
present (e.g. intrapancreatic portion of the common bile duct
with an irregular 2 cm length stenosis), patients should be con-
sidered as having a PC or cholangiocarcinoma [8]. The sudden
stenosis of the distal common bile duct with a general
upstream dilatation revealed in the MRCP and ERCP and also
the absence of a long (>one-third length of the MPD) or mul-
tiple strictures of the MPD were major features for not consider-
ing de autoimmune etiology. Routine workup diagnosis for
cancer was not negative and the patient undergone pancreatic
resection.
Two possibilities can be considered: one is that the patient
had really type 1 AIP but in a burn-out stage and another is
that the patient’s true diagnosis is an unclassified variant of
AIP (mixed type 1 and 2 AIP). Not all cases of AIP fit clearly into
the two subtypes. Some cases show the typical triumvirate
histologic type 1 disease (i.e. dense lymphoplasmacytic inflam-
mation, storiform-type fibrosis (Fig. 4), and obliterative phle-
bitis), but they also show more than an occasional intraductal
aggregate of neutrophils. Others show typical type 2 disease
pattern but with diffuse infiltrates of IgG4+ plasma cells, more
than 50/high power filed (HPF) like in our case (Fig. 5). Dense,
diffuse infiltrates of IgG4+ plasma cells that number >50/HPF
are reportedly highly specific for IgG4RD [10], but definitive
diagnosis of type 1 AIP should be based on the triumvirate hist-
ology. The absence of IgG4 cells does not necessarily imply the
diagnosis of type 2, as type 1 also can be seronegative.
Patients that underwent pancreatic resection represent a
failed or an insufficient routine workup diagnosis (up to 2–6%).
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Figure 4: H&E, ×100. Parenchymal fibrosis with focal storiform-type areas and a
lymphoplasmacytic infiltrate, that focally involves a vein, without overt oblit-
erative phlebitis.
Figure 5: Focal areas with more than 50 IgG4+ plasma cells per high-power field
were found, although a diffuse infiltrate was not present in this case.
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